NCT02122484View on ClinicalTrials.gov

Colchicine in Coronary Artery Bypass Graft (CABG)

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2014

Conditions
Elective Coronary Artery Bypass Graft Surgery
Interventions
DRUG

Colchicine

colchicine p.os 0.5 mg bid for two days before undergoing elective CABG surgery and eight days after the operation

Trial Locations (1)

11527

"Athens General Hospital G. Gennimatas", Athens

All Listed Sponsors
collaborator

Evangelismos Hospital

OTHER

lead

G.Gennimatas General Hospital

OTHER

NCT02122484 - Colchicine in Coronary Artery Bypass Graft (CABG) | Biotech Hunter | Biotech Hunter